This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What Makes Acadia Healthcare (ACHC) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Acadia Healthcare (ACHC) a Good Value Investor Stock Now?
by Zacks Equity Research
Let's see if Acadia Healthcare (ACHC) stock is a good choice for value-oriented investors right now from multiple angles.
Ensign Group (ENSG) Up 57.2% Year to Date: More Room for Rally?
by Zacks Equity Research
Ensign Group's (ENSG) strategic measures along with a solid capital position are likely to fetch revenues, which in turn, may perk up its share price.
Improving Patient Volumes Aid Select Medical's (SEM) Prospects
by Zacks Equity Research
Recovery in patient volumes owing to relaxation of government-imposed constraints is gradually restoring the patient admissions, thereby reinstating Select Medical (SEM) on the growth path.
Community Health (CYH) Soars 168.6% YTD: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) strategic measures along with the surge in telehealth visits are likely to fetch revenues, which in turn, may bump up its share price.
Amedisys (AMED) Banks on Home Health & Hospice Amid Cost Woe
by Zacks Equity Research
Amedisys (AMED) continues to benefit from the recent acquisitions of hospice care providers.
QIAGEN (QGEN) Launches COVID-19 Antigen Test With Ellume
by Zacks Equity Research
QIAGEN (QGEN) starts commercializing latest test after filing for FDA emergency use authorization (EUA) for symptomatic patients.
Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio
by Zacks Equity Research
Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.
Acadia Healthcare (ACHC) Is Up 14.3% in One Week: What You Should Know
by Zacks Equity Research
Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Acadia Healthcare's (ACHC) Shares Up on Q3 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) shares gain on third-quarter earnings beat, which has been driven by higher revenues. However, elevated costs have partially offset the results.
Acadia Healthcare (ACHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Acadia Healthcare's (ACHC) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Acadia Healthcare Company, Inc. (ACHC).
Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 23.64% and 4.14%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (ACHC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Acadia Healthcare (ACHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why You Should Retain Universal Health (UHS) for Now
by Zacks Equity Research
Riding high on its solvency position, strong segments and strategic initiatives, Universal Health (UHS) holds potential to reap benefits.
Here's Why You Should Retain Tenet Healthcare (THC) Stock
by Zacks Equity Research
Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.
HCA Healthcare (HCA) Announces Preliminary Results for Q3
by Zacks Equity Research
HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks Equity Research
HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.
HCA Healthcare, EVERFI's Course to Enhance Behavioral Health
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with EVERFI, which provides middle and high school students with a digital course to address mental health disorders.
Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC
Encompass Health Offers Senior Unsecured Notes Worth $400M
by Zacks Equity Research
Encompass Health (EHC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Acadia Healthcare Offers Senior Unsecured Notes for $475M
by Zacks Equity Research
Acadia Healthcare (ACHC) exhibits sharp business acumen by issuing senior notes to procure funds.
4 Hospital Stocks to Gain from Improving Admissions, Federal Aid
by Sapna Bagaria
Federal relief, higher admissions and cost containment are likely to aid the Zacks Medical-Hospital industry. HCA, UHS, CYH and THC are well-positioned to gain from a revival in admissions.
Why Should You Retain MEDNAX (MD) in Your Portfolio Now?
by Zacks Equity Research
Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.